Cargando…
BACE1 controls synaptic function through modulating release of synaptic vesicles
BACE1 initiates production of β-amyloid peptides (Aβ), which is associated with cognitive dysfunction in Alzheimer’s disease (AD) due to abnormal oligomerization and aggregation. While BACE1 inhibitors show strong reduction in Aβ deposition, they fail to improve cognitive function in patients, large...
Autores principales: | Das, Brati, Singh, Neeraj, Yao, Annie Y., Zhou, John, He, Wanxia, Hu, Xiangyou, Yan, Riqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760050/ https://www.ncbi.nlm.nih.gov/pubmed/34158621 http://dx.doi.org/10.1038/s41380-021-01166-2 |
Ejemplares similares
-
Role of BACE1 in Alzheimer’s synaptic function
por: Das, Brati, et al.
Publicado: (2017) -
BACE1 deletion in the adult mouse reverses preformed amyloid deposition and improves cognitive functions
por: Hu, Xiangyou, et al.
Publicado: (2018) -
Targeted BACE-1 inhibition in microglia enhances amyloid clearance and improved cognitive performance
por: Singh, Neeraj, et al.
Publicado: (2022) -
Bace1 Deletion in the Adult Reverses Epileptiform Activity and Sleep–wake Disturbances in AD Mice
por: Yao, Annie Y., et al.
Publicado: (2023) -
BACE-1 inhibition facilitates the transition from homeostatic microglia to DAM-1
por: Singh, Neeraj, et al.
Publicado: (2022)